SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-15-006427
Filing Date
2015-12-28
Accepted
2015-12-28 17:00:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 sc13da.htm SC 13D/A 129728
2 ex7.htm EX-7 48678
3 ex8.htm EX-8 8248
4 ex9.htm EX-9 10914
  Complete submission text file 0001493152-15-006427.txt   199047
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83793 | Film No.: 151309827
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1440 28TH STREET SUITE 9 BOULDER CO 80303
Business Address
Kammer Robert J (Filed by) CIK: 0001542484 (see all company filings)

Type: SC 13D/A